Skip to main content

Table 4 Variations of healthcare resource utilization recorded during benralizumab therapy

From: ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study

Item

After benralizumab

Primary care physician/GP office visits for asthma per patient

0.42

− 58%

Specialist visits for asthma per patient

2.35

− 2.1%

ED admissions for asthma per patient

0.025

− 87.5%

Hospitalizations for asthma per patient

0.021

− 79%

  1. Data are expressed as mean and % of variation vs index date. Evaluable patients, N = 195
  2. GP general practitioner, ED emergency department